HEADER TRANSFERASE 05-JAN-19 6J3O TITLE CRYSTAL STRUCTURE OF THE HUMAN PCAF BROMODOMAIN IN COMPLEX WITH TITLE 2 COMPOUND 12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE KAT2B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HISTONE ACETYLTRANSFERASE PCAF,HISTONE ACETYLASE PCAF,LYSINE COMPND 5 ACETYLTRANSFERASE 2B,P300/CBP-ASSOCIATED FACTOR,P/CAF,SPERMIDINE COMPND 6 ACETYLTRANSFERASE KAT2B; COMPND 7 EC: 2.3.1.48,2.3.1.57; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KAT2B, PCAF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CRYSTAL STRUCTURE OF THE HUMAN PCAF BROMODOMAIN IN COMPLEX WITH KEYWDS 2 COMPOUND 12, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.Y.HUANG,H.LI,L.L.LI,L.NIU,R.SEUPEL,C.Y.WU,G.B.LI,Y.M.YU, AUTHOR 2 P.E.BRENNAN,S.Y.YANG REVDAT 3 22-NOV-23 6J3O 1 REMARK REVDAT 2 22-MAY-19 6J3O 1 COMPND JRNL REMARK HETNAM REVDAT 2 2 1 ATOM REVDAT 1 01-MAY-19 6J3O 0 JRNL AUTH L.HUANG,H.LI,L.LI,L.NIU,R.SEUPEL,C.WU,W.CHENG,C.CHEN,B.DING, JRNL AUTH 2 P.E.BRENNAN,S.YANG JRNL TITL DISCOVERY OF PYRROLO[3,2- D]PYRIMIDIN-4-ONE DERIVATIVES AS A JRNL TITL 2 NEW CLASS OF POTENT AND CELL-ACTIVE INHIBITORS OF JRNL TITL 3 P300/CBP-ASSOCIATED FACTOR BROMODOMAIN. JRNL REF J.MED.CHEM. V. 62 4526 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30998845 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00096 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14RC3_3199: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.76 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 21873 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.7747 - 5.0848 0.99 1418 143 0.1886 0.1925 REMARK 3 2 5.0848 - 4.0365 1.00 1430 141 0.1838 0.2129 REMARK 3 3 4.0365 - 3.5264 1.00 1422 146 0.1936 0.2140 REMARK 3 4 3.5264 - 3.2040 1.00 1428 146 0.2236 0.2376 REMARK 3 5 3.2040 - 2.9744 1.00 1432 145 0.2472 0.2764 REMARK 3 6 2.9744 - 2.7991 1.00 1413 142 0.2579 0.3216 REMARK 3 7 2.7991 - 2.6589 1.00 1450 150 0.2809 0.3373 REMARK 3 8 2.6589 - 2.5431 1.00 1398 139 0.2869 0.3659 REMARK 3 9 2.5431 - 2.4452 1.00 1449 147 0.2868 0.3233 REMARK 3 10 2.4452 - 2.3609 1.00 1436 146 0.2842 0.3636 REMARK 3 11 2.3609 - 2.2870 1.00 1436 141 0.3380 0.3780 REMARK 3 12 2.2870 - 2.2217 0.94 1333 125 0.5393 0.6288 REMARK 3 13 2.2217 - 2.1632 0.99 1418 145 0.3786 0.3925 REMARK 3 14 2.1632 - 2.1104 0.99 1414 140 0.3617 0.3983 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 1851 REMARK 3 ANGLE : 0.505 2501 REMARK 3 CHIRALITY : 0.035 257 REMARK 3 PLANARITY : 0.003 311 REMARK 3 DIHEDRAL : 16.830 1119 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6J3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1300010411. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978897 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21934 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110 REMARK 200 RESOLUTION RANGE LOW (A) : 50.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.55300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5MKX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH 8.2, 26% PEG10000 REMARK 280 (V/V), 4% GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.76000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.30630 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.22667 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 50.76000 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 29.30630 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 33.22667 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 50.76000 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 29.30630 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.22667 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 58.61260 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 66.45333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 58.61260 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 66.45333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 58.61260 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 66.45333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 692 REMARK 465 HIS A 693 REMARK 465 HIS A 694 REMARK 465 HIS A 695 REMARK 465 HIS A 696 REMARK 465 HIS A 697 REMARK 465 HIS A 698 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 GLY A 701 REMARK 465 VAL A 702 REMARK 465 ASP A 703 REMARK 465 LEU A 704 REMARK 465 GLY A 705 REMARK 465 THR A 706 REMARK 465 GLU A 707 REMARK 465 ASN A 708 REMARK 465 LEU A 709 REMARK 465 TYR A 710 REMARK 465 PHE A 711 REMARK 465 GLN A 712 REMARK 465 SER A 713 REMARK 465 MET A 714 REMARK 465 GLY A 715 REMARK 465 LYS A 716 REMARK 465 GLU A 717 REMARK 465 LYS A 718 REMARK 465 SER A 719 REMARK 465 LYS A 720 REMARK 465 GLU A 721 REMARK 465 PRO A 722 REMARK 465 ARG A 723 REMARK 465 ASP A 724 REMARK 465 PRO A 725 REMARK 465 MET B 692 REMARK 465 HIS B 693 REMARK 465 HIS B 694 REMARK 465 HIS B 695 REMARK 465 HIS B 696 REMARK 465 HIS B 697 REMARK 465 HIS B 698 REMARK 465 SER B 699 REMARK 465 SER B 700 REMARK 465 GLY B 701 REMARK 465 VAL B 702 REMARK 465 ASP B 703 REMARK 465 LEU B 704 REMARK 465 GLY B 705 REMARK 465 THR B 706 REMARK 465 GLU B 707 REMARK 465 ASN B 708 REMARK 465 LEU B 709 REMARK 465 TYR B 710 REMARK 465 PHE B 711 REMARK 465 GLN B 712 REMARK 465 SER B 713 REMARK 465 MET B 714 REMARK 465 GLY B 715 REMARK 465 LYS B 716 REMARK 465 GLU B 717 REMARK 465 LYS B 718 REMARK 465 SER B 719 REMARK 465 LYS B 720 REMARK 465 GLU B 721 REMARK 465 PRO B 722 REMARK 465 ARG B 723 REMARK 465 ASP B 724 REMARK 465 PRO B 725 REMARK 465 ASP B 831 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 765 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 778 CG CD CE NZ REMARK 470 LYS A 786 CD CE NZ REMARK 470 LYS B 785 CG CD CE NZ REMARK 470 LYS B 786 CD CE NZ REMARK 470 GLU B 808 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 780 32.83 73.41 REMARK 500 LYS A 786 87.48 -64.05 REMARK 500 LEU A 787 -65.87 163.10 REMARK 500 ILE B 764 92.86 62.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1020 DISTANCE = 5.89 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B4L A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B4L B 900 DBREF 6J3O A 715 831 UNP Q92831 KAT2B_HUMAN 715 831 DBREF 6J3O B 715 831 UNP Q92831 KAT2B_HUMAN 715 831 SEQADV 6J3O MET A 692 UNP Q92831 INITIATING METHIONINE SEQADV 6J3O HIS A 693 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS A 694 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS A 695 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS A 696 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS A 697 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS A 698 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER A 699 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER A 700 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLY A 701 UNP Q92831 EXPRESSION TAG SEQADV 6J3O VAL A 702 UNP Q92831 EXPRESSION TAG SEQADV 6J3O ASP A 703 UNP Q92831 EXPRESSION TAG SEQADV 6J3O LEU A 704 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLY A 705 UNP Q92831 EXPRESSION TAG SEQADV 6J3O THR A 706 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLU A 707 UNP Q92831 EXPRESSION TAG SEQADV 6J3O ASN A 708 UNP Q92831 EXPRESSION TAG SEQADV 6J3O LEU A 709 UNP Q92831 EXPRESSION TAG SEQADV 6J3O TYR A 710 UNP Q92831 EXPRESSION TAG SEQADV 6J3O PHE A 711 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLN A 712 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER A 713 UNP Q92831 EXPRESSION TAG SEQADV 6J3O MET A 714 UNP Q92831 EXPRESSION TAG SEQADV 6J3O MET B 692 UNP Q92831 INITIATING METHIONINE SEQADV 6J3O HIS B 693 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS B 694 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS B 695 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS B 696 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS B 697 UNP Q92831 EXPRESSION TAG SEQADV 6J3O HIS B 698 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER B 699 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER B 700 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLY B 701 UNP Q92831 EXPRESSION TAG SEQADV 6J3O VAL B 702 UNP Q92831 EXPRESSION TAG SEQADV 6J3O ASP B 703 UNP Q92831 EXPRESSION TAG SEQADV 6J3O LEU B 704 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLY B 705 UNP Q92831 EXPRESSION TAG SEQADV 6J3O THR B 706 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLU B 707 UNP Q92831 EXPRESSION TAG SEQADV 6J3O ASN B 708 UNP Q92831 EXPRESSION TAG SEQADV 6J3O LEU B 709 UNP Q92831 EXPRESSION TAG SEQADV 6J3O TYR B 710 UNP Q92831 EXPRESSION TAG SEQADV 6J3O PHE B 711 UNP Q92831 EXPRESSION TAG SEQADV 6J3O GLN B 712 UNP Q92831 EXPRESSION TAG SEQADV 6J3O SER B 713 UNP Q92831 EXPRESSION TAG SEQADV 6J3O MET B 714 UNP Q92831 EXPRESSION TAG SEQRES 1 A 140 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 140 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY LYS GLU SEQRES 3 A 140 LYS SER LYS GLU PRO ARG ASP PRO ASP GLN LEU TYR SER SEQRES 4 A 140 THR LEU LYS SER ILE LEU GLN GLN VAL LYS SER HIS GLN SEQRES 5 A 140 SER ALA TRP PRO PHE MET GLU PRO VAL LYS ARG THR GLU SEQRES 6 A 140 ALA PRO GLY TYR TYR GLU VAL ILE ARG PHE PRO MET ASP SEQRES 7 A 140 LEU LYS THR MET SER GLU ARG LEU LYS ASN ARG TYR TYR SEQRES 8 A 140 VAL SER LYS LYS LEU PHE MET ALA ASP LEU GLN ARG VAL SEQRES 9 A 140 PHE THR ASN CYS LYS GLU TYR ASN PRO PRO GLU SER GLU SEQRES 10 A 140 TYR TYR LYS CYS ALA ASN ILE LEU GLU LYS PHE PHE PHE SEQRES 11 A 140 SER LYS ILE LYS GLU ALA GLY LEU ILE ASP SEQRES 1 B 140 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 140 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY LYS GLU SEQRES 3 B 140 LYS SER LYS GLU PRO ARG ASP PRO ASP GLN LEU TYR SER SEQRES 4 B 140 THR LEU LYS SER ILE LEU GLN GLN VAL LYS SER HIS GLN SEQRES 5 B 140 SER ALA TRP PRO PHE MET GLU PRO VAL LYS ARG THR GLU SEQRES 6 B 140 ALA PRO GLY TYR TYR GLU VAL ILE ARG PHE PRO MET ASP SEQRES 7 B 140 LEU LYS THR MET SER GLU ARG LEU LYS ASN ARG TYR TYR SEQRES 8 B 140 VAL SER LYS LYS LEU PHE MET ALA ASP LEU GLN ARG VAL SEQRES 9 B 140 PHE THR ASN CYS LYS GLU TYR ASN PRO PRO GLU SER GLU SEQRES 10 B 140 TYR TYR LYS CYS ALA ASN ILE LEU GLU LYS PHE PHE PHE SEQRES 11 B 140 SER LYS ILE LYS GLU ALA GLY LEU ILE ASP HET B4L A 900 19 HET B4L B 900 19 HETNAM B4L 3-METHYL-2-[[(3~{R})-1-METHYLPIPERIDIN-3-YL]AMINO]- HETNAM 2 B4L 5~{H}-PYRROLO[3,2-D]PYRIMIDIN-4-ONE FORMUL 3 B4L 2(C13 H19 N5 O) FORMUL 5 HOH *44(H2 O) HELIX 1 AA1 ASP A 726 HIS A 742 1 17 HELIX 2 AA2 GLN A 743 MET A 749 5 7 HELIX 3 AA3 GLY A 759 VAL A 763 5 5 HELIX 4 AA4 ASP A 769 ASN A 779 1 11 HELIX 5 AA5 SER A 784 ASN A 803 1 20 HELIX 6 AA6 SER A 807 ALA A 827 1 21 HELIX 7 AA7 GLN B 727 SER B 741 1 15 HELIX 8 AA8 HIS B 742 MET B 749 5 8 HELIX 9 AA9 ASP B 769 ASN B 779 1 11 HELIX 10 AB1 SER B 784 ASN B 803 1 20 HELIX 11 AB2 SER B 807 ALA B 827 1 21 SITE 1 AC1 6 PRO A 747 PRO A 751 GLU A 756 ASN A 803 SITE 2 AC1 6 TYR A 809 HOH A1018 SITE 1 AC2 6 PRO B 747 PRO B 751 GLU B 756 ALA B 757 SITE 2 AC2 6 ASN B 803 TYR B 809 CRYST1 101.520 101.520 99.680 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009850 0.005687 0.000000 0.00000 SCALE2 0.000000 0.011374 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010032 0.00000